Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer

Published 2014 View Full Article

Authors

Keywords

Journal

CLINICAL CANCER RESEARCH

Volume 20, Issue 16, Pages 4240-4250

Publisher

American Association for Cancer Research (AACR)

Online

2014-06-12

DOI

10.1158/1078-0432.ccr-13-2752

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CLINICAL CANCER RESEARCH

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.